{
  "Country": "FR",
  "PICOs": [
    {
      "Population": "Adult patients with non-small cell bronchial cancer (NCBC) KRAS p.G12C metastatic mutated, pre-treated",
      "Intervention": "Sotorasib",
      "Comparator": "None (non-comparative Phase I/II study)",
      "Outcomes": "Objective response rate, adverse events, tolerability"
    },
    {
      "Population": "Patients who received at least one dose of sotorasib",
      "Intervention": "Sotorasib",
      "Comparator": "None (safety population analysis)",
      "Outcomes": "Adverse events, serious adverse events, treatment discontinuation due to adverse events"
    }
  ]
}